218 related articles for article (PubMed ID: 9586576)
1. Increased anticoagulant activity of recombinant thrombomodulin modified with glycosaminoglycan.
Edano T; Inoue K; Yoshizaki H; Yamamoto S; Komine N; Tabunoki H; Sawada H; Koshi T; Murakami A; Wada Y; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):375-81. PubMed ID: 9586576
[TBL] [Abstract][Full Text] [Related]
2. Protein C activation by recombinant thrombomodulin in plasma.
Edano T; Komine N; Yoshizaki H; Ohkuchi M
Biol Pharm Bull; 1998 Feb; 21(2):177-9. PubMed ID: 9514616
[TBL] [Abstract][Full Text] [Related]
3. Importance of sialic acid in recombinant thrombomodulin in terms of pharmacokinetics and separation of desialyzed glycoprotein.
Edano T; Koshi T; Yoshizaki H; Kumai N; Habata Y; Koide T; Mizoguchi T; Yamamoto S; Kimata H; Ohkuchi M
Biol Pharm Bull; 1998 Apr; 21(4):382-5. PubMed ID: 9586577
[TBL] [Abstract][Full Text] [Related]
4. ATIII-independence of anticoagulant effect of human urinary soluble thrombomodulin.
Imada K; Takahashi Y; Hosaka Y; Adachi T; Niina H; Mochizuki H
Blood Coagul Fibrinolysis; 1999 Dec; 10(8):503-11. PubMed ID: 10636462
[TBL] [Abstract][Full Text] [Related]
5. Species specificity of the anticoagulant activity of human urinary soluble thrombomodulin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Mochizuki H
Thromb Res; 1998 Feb; 89(4):187-97. PubMed ID: 9651146
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats.
Gonda Y; Hirata S; Saitoh K; Aoki Y; Mohri M; Gomi K; Sugihara T; Kiyota T; Yamamoto S; Ishida T
Thromb Res; 1993 Aug; 71(4):325-35. PubMed ID: 8236161
[TBL] [Abstract][Full Text] [Related]
7. Amplified anticoagulant activity of tissue factor-targeted thrombomodulin: in-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin.
Wang YX; Wu C; Vincelette J; Martin-McNulty B; Alexander S; Larsen B; Light DR; McLean K
Thromb Haemost; 2006 Sep; 96(3):317-24. PubMed ID: 16953273
[TBL] [Abstract][Full Text] [Related]
8. The glycosylation sites and structural characteristics of oligosaccharides on recombinant human thrombomodulin.
Edano T; Kumai N; Mizoguchi T; Ohkuchi M
Int J Biochem Cell Biol; 1998 Jan; 30(1):77-88. PubMed ID: 9597755
[TBL] [Abstract][Full Text] [Related]
9. Soluble thrombomodulin purified from human urine exhibits a potent anticoagulant effect in vitro and in vivo.
Takahashi Y; Hosaka Y; Niina H; Nagasawa K; Naotsuka M; Sakai K; Uemura A
Thromb Haemost; 1995 May; 73(5):805-11. PubMed ID: 7482407
[TBL] [Abstract][Full Text] [Related]
10. Effect of human urinary thrombomodulin on endotoxin-induced intravascular coagulation and pulmonary vascular injury in rats.
Uchiba M; Okajima K; Murakami K; Johno M; Okabe H; Takatsuki K
Am J Hematol; 1997 Feb; 54(2):118-23. PubMed ID: 9034285
[TBL] [Abstract][Full Text] [Related]
11. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
12. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
13. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
[TBL] [Abstract][Full Text] [Related]
14. Effect of activated human protein C on disseminated intravascular coagulation induced by lipopolysaccharide in rats.
Aoki Y; Ota M; Katsuura Y; Komoriya K; Nakagaki T
Arzneimittelforschung; 2000 Sep; 50(9):809-15. PubMed ID: 11050697
[TBL] [Abstract][Full Text] [Related]
15. Human urinary soluble thrombomodulin (MR-33) improves disseminated intravascular coagulation without affecting bleeding time in rats: comparison with low molecular weight heparin.
Takahashi Y; Hosaka Y; Imada K; Adachi T; Niina H; Watanabe M; Mochizuki H
Thromb Haemost; 1997 Apr; 77(4):789-95. PubMed ID: 9134660
[TBL] [Abstract][Full Text] [Related]
16. [Thrombomodulin].
Ohmori Y; Takahashi Y
Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):283-9. PubMed ID: 11215378
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with soluble thrombomodulin prevents intrasinusoidal coagulation and liver dysfunction following extensive hepatectomy in cirrhotic rats.
Kaido T; Yoshikawa A; Seto S; Yamaoka S; Furuyama H; Arii S; Takahashi Y; Imamura M
Thromb Haemost; 1999 Oct; 82(4):1302-6. PubMed ID: 10544918
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin.
Hosaka Y; Higuchi T; Tsumagari M; Ishii H
Cancer Lett; 2000 Dec; 161(2):231-40. PubMed ID: 11090974
[TBL] [Abstract][Full Text] [Related]
19. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
[TBL] [Abstract][Full Text] [Related]
20. The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis).
Mohri M; Gonda Y; Oka M; Aoki Y; Gomi K; Kiyota T; Sugihara T; Yamamoto S; Ishida T; Maruyama I
Blood Coagul Fibrinolysis; 1997 Jul; 8(5):274-83. PubMed ID: 9282791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
